U.S. Medical Weight Loss Clinics Market Size to Reach USD 4.50 Billion by 2033, Growing at 4.31% CAGR
U.S. Medical Weight Loss Clinics Market Size and Growth
The U.S. medical weight loss clinics market size was exhibited at USD 2.95 billion in 2023 and is projected to hit around USD 4.50 billion by 2033, growing at a CAGR of 4.31% during the forecast period 2024 to 2033.
Download Free Sample Copy for Better Understanding@ https://www.novaoneadvisor.com/report/sample/8169
Key Takeaways:
The increasing prevalence of obesity in the adult U.S. population is expected to drive the growth of the market. According? to the CDC statistics of 2023, around 20.7% of people aged 18 to 24 years have reported suffering from obesity, and around 39.3% of adults aged 45 to 54 years of age reported suffering from obesity in the U.S. Obesity is the second leading cause of mortality in the U.S. Obese people have higher risks for heart conditions, diabetes, high blood pressures, and others major health conditions.
Furthermore, patients are shifting from surgical weight loss methods towards non-surgical weight loss methods, owing to similar efficiency and results of the procedures. According? to the American Society for Metabolic and Bariatric Surgery, estimated 198,651 bariatric surgeries were performed in 2020 in the U.S., a decline from 256,000 surgeries performed in 2019. The shift of patients can be attributed to the higher cost associated with bariatric surgeries and the risk associated with surgical procedures. According? to the American Society for Metabolic and Bariatric Surgery, the average cost of bariatric surgery in the U.S. is around USD 17,000 to USD 26,000. This is much higher compared to medical weight loss programs.
Moreover, with several weight loss medications launched in the U.S., the demand for medical weight loss treatments is constantly rising. For instance, in June 2021, the U.S. FDA approved Wegovy (semaglutide) for chronic weight management in adults. The drug is intended to be used in combination with exercise and a healthy diet and reported 15% to 18% weight loss findings during the clinical trials of the product. Moreover , in May 2023, the Eli Lilly Company announced to seek U.S. FDA approval for Trizepatide for weight loss in the U.S. The drug is approved for type-2 diabetes and has reported positive weight loss effects in clinical trials.
The U.S. weight loss clinic industry was negatively impacted by the COVID-19 pandemic in the early phase due to the closure of the programs to maintain social distancing to curb the spread of the virus. According to the study published in the MedScape on VHA MOVE Weight Management Program during and before the pandemic, the monthly participation in the program in April and May 2020 was around 50% to 60% lower compared to the same period in 2019. However, participation started to increase in the latter months of 2020 and reached pre-pandemic levels in 2021. This can be attributed to the shift of patients from in-person programs to telehealth programs.
U.S. Medical Weight Loss Clinics Market By Ownership Insights
Based on the ownership, the market is categorized into hospital-based and standalone clinics. The standalone segment dominated with a revenue share of 60.61% in 2023. This can be attributed to the presence of a large number of clinics at different locations and the presence of specialized staff in the centers. Moreover, the increased patient burden on hospitals during the pandemic has shifted patients from hospital-based settings toward standalone facilities.
These clinics offer personalized programs at a discounted rate and are available at many locations. For instance, Medi IP, LLC has a presence in more than 103 locations in the U.S. and serves more than 300,000 patients in the U.S. Market players are opening new clinics at different locations to increase their market presence. For instance, in August 2023, Modern Medical Weight Loss opened a new medical weight loss clinic in Kentucky offering advanced medical weight loss solutions.
U.S. Medical Weight Loss Clinics Market By Regional Insights
Based on region, the market is divided into Southeast, West, Midwest, Southwest, and Northeast. The Southeast region dominated with the largest revenue share of 24.0% in 2023. This can be attributed to the higher prevalence of the obese population in the region, majorly in the Kentucky and West Virginia states, and higher physician services expenditures compared to other states. According to the CDC 2021 Adult Obesity Prevalence Maps, more than 40% of the adults in the Kentucky and West Virginia suffered from obesity.
Southwest region is expected to witness the fastest growth over the forecast period owing to the growing number of obese people and the rising number of medical weight loss clinics in the region. For instance, in November 2023, Texas Health Medical Group opened its new medical weight loss clinic in Dallas and the surrounding area in Texas. The clinic is offering a medical weight loss program with the use of a GLP-1 drug.
Moreover, the Northeast segment is expected to witness significant growth over the forecast period. This growth can be attributed to the growing prevalence of obesity in the region. According? to the CDC 2021 Adult Obesity Prevalence Maps, the prevalence of obesity in the Northeast in 2021 was 29.9%, higher compared to 29.0% in 2019.
Some of the prominent players in the U.S. medical weight loss clinics market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. medical weight loss clinics market
Ownership
Regional
Download Free Sample Copy for Better Understanding@ https://www.novaoneadvisor.com/report/sample/8169
Table of Content
Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.3.1. Information procurement
1.3.2. Purchased Database
1.3.3. Internal Database
1.3.4. Secondary Sources
1.3.5. Primary Research
1.3.6. Details of Primary Research
1.4. Information or Data Analysis
1.4.1. Data Analysis Models
1.5. 1.5 Market Formulation & Validation
1.5.1. Volume Price Analysis
1.6. List of Secondary Sources
1.7. List of Abbreviations
1.8. Research Objectives
1.8.1. Objective - 1
1.8.2. Objective - 2
1.8.3. Objective - 3
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Dynamics
3.1.1. Market Driver Analysis
3.1.1.1. Rise in prevalence of obesity
3.1.1.2. Growing aesthetic desire to look fit
3.1.1.3. Shift of patients from surgical weight loss treatment to non-surgical treatment
3.1.2. Market Restraint Analysis
3.1.2.1. Lack of skilled healthcare staff
3.1.2.2. Gap between demand and supply of physicians
3.2. Industry Analysis Tools
3.2.1. Porter’s Five Forces Analysis
3.2.2. PESTLE Analysis
3.3. COVID-19 Impact Analysis
Chapter 4. U.S. Medical Weight Loss Clinics Market: Ownership Estimates & Trend Analysis
4.1. Segment Definitions
4.2. U.S. Medical Weight Loss Clinics Market: Segment Dashboard
4.3. U.S. Medical Weight Loss Clinics Market: Ownership Movement & Market Share Analysis
4.4. Hospital-based
4.4.1. Hospital-based Market, 2021 - 2033
4.5. Standalone
4.5.1. Standalone Market, 2021 - 2033
Chapter 5. U.S. Medical Weight Loss Clinics Market: Region Estimates & Trend Analysis
5.1. Segment Definitions
5.2. U.S. Medical Weight Loss Clinics Market: Segment Dashboard
5.3. U.S. Medical Weight Loss Clinics Market: Region Movement & Market share Analysis
5.4. West
5.4.1. West Market, 2021 - 2033
5.5. Midwest
5.5.1. Midwest Market, 2021 - 2033
5.6. Northeast
5.6.1. Northeast Market, 2021 - 2033
5.7. Southeast
领英推荐
5.7.1. Southeast Market, 2021 - 2033
5.8. Southwest
5.8.1. Southwest Market, 2021 - 2033
Chapter 6. Competitive Landscape
6.1. Company Profiles
6.1.1. Cleveland Clinic
6.1.1.1. Overview
6.1.1.2. Financial Performance
6.1.1.3. Service Benchmarking
6.1.1.4. Strategic Initiatives
6.1.2. Medical Weight Loss Clinic
6.1.2.1. Overview
6.1.2.2. Financial Performance
6.1.2.3. Service Benchmarking
6.1.2.4. Strategic Initiatives
6.1.3. Rivas Weight Loss
6.1.3.1. Overview
6.1.3.2. Financial Performance
6.1.3.3. Service Benchmarking
6.1.3.4. Strategic Initiatives
6.1.4. Medi IP, LLC (Medi-Weightloss)
6.1.4.1. Overview
6.1.4.2. Financial Performance
6.1.4.3. Service Benchmarking
6.1.4.4. Strategic Initiatives
6.1.5. NYU Langone Hospitals
6.1.5.1. Overview
6.1.5.2. Financial Performance
6.1.5.3. Service Benchmarking
6.1.5.4. Strategic Initiatives
6.1.6. Stanford Health Care
6.1.6.1. Overview
6.1.6.2. Financial Performance
6.1.6.3. Service Benchmarking
6.1.6.4. Strategic Initiatives
6.1.7. UCLA Health
6.1.7.1. Overview
6.1.7.2. Financial Performance
6.1.7.3. Service Benchmarking
6.1.7.4. Strategic Initiatives
6.1.8. Long Island Weight Loss Institute
6.1.8.1. Overview
6.1.8.2. Financial Performance
6.1.8.3. Service Benchmarking
6.1.8.4. Strategic Initiatives
6.1.9. Med-Fit Medical Weight Loss
6.1.9.1. Overview
6.1.9.2. Financial Performance
6.1.9.3. Service Benchmarking
6.1.9.4. Strategic Initiatives
6.1.10. Cedars-Sinai
6.1.10.1. Overview
6.1.10.2. Financial Performance
6.1.10.3. Service Benchmarking
6.1.10.4. Strategic Initiatives
6.1.11. Allegheny Health Network
6.1.11.1. Overview
6.1.11.2. Financial Performance
6.1.11.3. Service Benchmarking
6.1.11.4. Strategic Initiatives
6.1.12. Options Medical Weight Loss
6.1.12.1. Overview
6.1.12.2. Financial Performance
6.1.12.3. Service Benchmarking
6.1.12.4. Strategic Initiatives
6.2. Company Categorization
6.3. Company Market Position Analysis
6.4. Strategy Mapping
Chapter 7. Recommendations/Key Market Insights
Quick Buy This Premium Report From Here: https://www.novaoneadvisor.com/report/checkout/8169?
Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com
You can place an order or ask any questions, please feel free to [email protected]| +1 9197 992 333
About US
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
Connect with Us
Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
·??????? IND Address: 2nd Floor,Shreeleela Plaza, Baner Road, Pune, Maharashtra - 411045
·??????? Call: USA - +1 650 460 3308 | IND - +91 8793322019 | Europe +442080772818
·??????? [email protected]